lidocaine hydrochloride and dextrose

Generic: lidocaine hydrochloride anhydrous and dextrose monohydrate

Labeler: propharma distribution
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name lidocaine hydrochloride and dextrose
Generic Name lidocaine hydrochloride anhydrous and dextrose monohydrate
Labeler propharma distribution
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

dextrose monohydrate 5 g/100mL, lidocaine hydrochloride anhydrous .4 g/100mL

Manufacturer
ProPharma Distribution

Identifiers & Regulatory

Product NDC 84549-594
Product ID 84549-594_48c0ee87-f723-1a71-e063-6394a90a72d1
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA019830
Listing Expiration 2027-12-31
Marketing Start 1992-04-08

Pharmacologic Class

Classes
amide local anesthetic [epc] amides [cs] antiarrhythmic [epc] local anesthesia [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 84549594
Hyphenated Format 84549-594

Supplemental Identifiers

RxCUI
1737742
UNII
LX22YL083G EC2CNF7XFP

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lidocaine hydrochloride and dextrose (source: ndc)
Generic Name lidocaine hydrochloride anhydrous and dextrose monohydrate (source: ndc)
Application Number NDA019830 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 5 g/100mL
  • .4 g/100mL
source: ndc
Packaging
  • 250 mL in 1 CONTAINER (84549-594-20)
source: ndc

Packages (1)

84549-594-20 250 mL in 1 CONTAINER (84549-594-20)

Ingredients (2)

dextrose monohydrate (5 g/100mL) lidocaine hydrochloride anhydrous (.4 g/100mL)

Linked Drug Pages (1)

Lidocaine Hydrochloride and Dextrose ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "48c0ee87-f723-1a71-e063-6394a90a72d1", "openfda": {"unii": ["LX22YL083G", "EC2CNF7XFP"], "rxcui": ["1737742"], "spl_set_id": ["48c0ee87-f722-1a71-e063-6394a90a72d1"], "manufacturer_name": ["ProPharma Distribution"]}, "finished": true, "packaging": [{"sample": false, "description": "250 mL in 1 CONTAINER (84549-594-20)", "package_ndc": "84549-594-20", "marketing_start_date": "20260119"}], "brand_name": "Lidocaine Hydrochloride and Dextrose", "product_id": "84549-594_48c0ee87-f723-1a71-e063-6394a90a72d1", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Antiarrhythmic [EPC]", "Local Anesthesia [PE]"], "product_ndc": "84549-594", "generic_name": "LIDOCAINE HYDROCHLORIDE ANHYDROUS and DEXTROSE MONOHYDRATE", "labeler_name": "ProPharma Distribution", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lidocaine Hydrochloride and Dextrose", "active_ingredients": [{"name": "DEXTROSE MONOHYDRATE", "strength": "5 g/100mL"}, {"name": "LIDOCAINE HYDROCHLORIDE ANHYDROUS", "strength": ".4 g/100mL"}], "application_number": "NDA019830", "marketing_category": "NDA", "marketing_start_date": "19920408", "listing_expiration_date": "20271231"}